NYSE · A
Healthcare · Medical - Diagnostics & Research
$156.47
Up+$0.13 (+0.08%)
Updated Sep 20, 2026, 10:20 AM
SID Score
7.2/10
Composite research score
Smart Money
58/100
Neutral
Price performance
1M range · 19 trading sessions · Daily adjusted prices
A closed at $156.47 after 19 trading sessions, up 1.98% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | $156.00 | $156.73 | $154.60 | $156.47 | 4.85M |
| Sep 17, 2026 | $156.00 | $156.89 | $154.03 | $156.34 | 2.89M |
| Sep 16, 2026 | $150.83 | $155.52 | $150.30 | $153.69 | 2.51M |
| Sep 15, 2026 | $147.00 | $150.96 | $147.00 | $150.27 | 1.68M |
| Sep 14, 2026 | $148.00 | $148.50 | $144.65 | $146.80 | 1.65M |
| Sep 11, 2026 | $144.48 | $146.975 | $143.18 | $146.93 | 1.78M |
| Sep 10, 2026 | $142.58 | $144.145 | $141.25 | $143.12 | 1.52M |
| Sep 9, 2026 | $145.23 | $146.46 | $143.75 | $144.75 | 1.85M |
| Sep 8, 2026 | $148.02 | $149.215 | $145.97 | $146.85 | 1.6M |
| Sep 4, 2026 | $148.97 | $151.59 | $147.78 | $150.86 | 1.83M |
| Sep 3, 2026 | $152.63 | $154.295 | $147.81 | $149.98 | 2.26M |
| Sep 2, 2026 | $149.05 | $152.72 | $147.60 | $151.39 | 3.13M |
| Sep 1, 2026 | $153.55 | $154.59 | $149.18 | $149.93 | 2.72M |
| Aug 31, 2026 | $152.68 | $154.03 | $151.635 | $153.56 | 2.77M |
| Aug 28, 2026 | $156.02 | $156.095 | $152.765 | $153.84 | 2.97M |
| Aug 27, 2026 | $159.35 | $163.75 | $155.46 | $157.69 | 3.2M |
| Aug 26, 2026 | $152.45 | $155.42 | $152.44 | $155.08 | 3.21M |
| Aug 25, 2026 | $153.90 | $155.16 | $152.27 | $154.77 | 2.43M |
| Aug 24, 2026 | $157.13 | $157.655 | $152.17 | $153.43 | 3.95M |
The latest Smart Investors Daily articles mentioning A.
A research
Company profile and research snapshot.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 27, 2026 | Bernstein | Outperform | — |
| Aug 27, 2026 | TD Cowen | Buy | — |
| Aug 27, 2026 | JP Morgan | Overweight | — |
| Aug 27, 2026 | Goldman Sachs | Buy | — |
| Aug 27, 2026 | Citigroup | Buy | — |
Generated Sep 19, 2026, 9:00 PM
Agilent Technologies is ticking up modestly on a day featuring two announcements that underscore the company's strategic positioning in digital pathology and its commitment to shareholder returns. The 0.08% gain reflects a measured market response to news spanning both innovation initiatives and dividend policy confirmation.
Bottom line: Agilent's modest gains reflect balanced sentiment around its digital pathology ambitions paired with solid shareholder capital return policies, though the modest 0.08% move suggests limited conviction from the market. Investors should monitor pathology lab adoption rates and competitive positioning in digital diagnostics while appreciating the company's dividend consistency, but remain cautious about execution risks and longer-term market penetration uncertainties.
Yahoo · Sep 19, 2026
On September 4, Agilent Technologies (NYSE:A) launched a slide scanner in the United States that can hold up to 540 glass slides at once. The Agilent S540MD has FDA clearance and targets labs buried in samples and eyeing AI-assisted workflows. The launch is easy to overlook, but it arrives alongside a strong quarter, and that […]
Yahoo · Sep 16, 2026
SANTA CLARA, Calif., September 16, 2026--First paragraph, second sentence of release should read: The quarterly dividend will be paid on October 28, 2026, to all shareholders of record as of the close of business on October 6, 2026. (instead of The quarterly dividend will be paid on October 6, 2026, to all shareholders of record as of the close of business on October 28, 2026.).
Yahoo · Sep 16, 2026
Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth rates as they’ve already captured significant portions of their markets.
Yahoo · Sep 11, 2026
Opportunities span advanced MRI, particle accelerators, fusion energy, mass spectrometry, quantum computing and transportation. Better superconducting materials and cooling can cut operating costs, while supply-chain shifts open new sourcing options.Dublin, Sept. 11, 2026 (GLOBE NEWSWIRE) -- "Superconducting Magnets - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Superconducting Magnets was valued at US$3.9 Billion in 2024 and is proj
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning A.
